Glucolipotoxicity: Fuel Excess and β-Cell Dysfunction
Open accessThe DOI matches its Crossref record; 198 of the 198 references it cites were found in a registry or an index.
Abstract
Glucotoxicity, lipotoxicity, and glucolipotoxicity are secondary phenomena that are proposed to play a role in all forms of type 2 diabetes. The underlying concept is that once the primary pathogenesis of diabetes is established, probably involving both genetic and environmental forces, hyperglycemia and very commonly hyperlipidemia ensue and thereafter exert additional damaging or toxic effects on the beta-cell. In addition to their contribution to the deterioration of beta-cell function after the onset of the disease, elevations of plasma fatty acid levels that often accompany insulin resistance may, as glucose levels begin to rise outside of the normal range, also play a pathogenic role in the early stages of the disease. Because hyperglycemia is a prerequisite for lipotoxicity to occur, the term glucolipotoxicity, rather than lipotoxicity, is more appropriate to describe deleterious effects of lipids on beta-cell function. In vitro and in vivo evidence supporting the concept of glucotoxicity is presented first, as well as a description of the underlying mechanisms with an emphasis on the role of oxidative stress. Second, we discuss the functional manifestations of glucolipotoxicity on insulin secretion, insulin gene expression, and beta-cell death, and the role of glucose in the mechanisms of glucolipotoxicity. Finally, we attempt to define the role of these phenomena in the natural history of beta-cell compensation, decompensation, and failure during the course of type 2 diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The basis for this loss is multifactorial, and includes glucolipotoxicity32 and amyloid deposition that result in β-cell apoptosis through oxidative as well as endoplasmic reticulum stress31.”
From Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future (2014) · cites this paper as [32]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls
The Wellcome Trust Case Control Consortium, Management Committee, Burton, P. R., Clayton, D. G., Cardon, L. R., Craddock, N., Deloukas, P., Duncanson, A., Kwiatkowski, D. P., McCarthy, M. I., et al. (2007) · Nature · doi:10.1038/nature05911 · Cited by 9,442
Biochemistry and molecular cell biology of diabetic complications
Brownlee, M. (2001) · Nature · doi:10.1038/414813a · Cited by 9,107
β-Cell Deficit and Increased β-Cell Apoptosis in Humans With Type 2 Diabetes
Butler, A. E., Janson, J., Bonner-Weir, S., Ritzel, R., Rizza, R. A., & Butler, P. C. (2003) · Diabetes · doi:10.2337/diabetes.52.1.102 · Cited by 4,011
A genome-wide association study identifies novel risk loci for type 2 diabetes
Sladek, R., Rocheleau, G., Rung, J., Dina, C., Shen, L., Serre, D., Boutin, P., Vincent, D., Belisle, A., Hadjadj, S., et al. (2007) · Nature · doi:10.1038/nature05616 · Cited by 2,993
Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels
Saxena, R., Voight, B. F., Lyssenko, V., Burtt, N. P., de Bakker, P. I. W., Chen, H., Roix, J. J., Kathiresan, S., Hirschhorn, J. N., Daly, M. J., et al. (2007) · Science · doi:10.1126/science.1142358 · Cited by 2,843
A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants
Scott, L. J., Mohlke, K. L., Bonnycastle, L. L., Willer, C. J., Li, Y., Duren, W. L., Erdos, M. R., Stringham, H. M., Chines, P. S., Jackson, A. U., et al. (2007) · Science · doi:10.1126/science.1142382 · Cited by 2,753
Reactive oxygen species have a causal role in multiple forms of insulin resistance
Houstis, N., Rosen, E. D., & Lander, E. S. (2006) · Nature · doi:10.1038/nature04634 · Cited by 2,525
A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction
Clément, K., Vaisse, C., Lahlou, N., Cabrol, S., Pelloux, V., Cassuto, D., Gourmelen, M., Dina, C., Chambaz, J., Lacorte, J.-M., et al. (1998) · Nature · doi:10.1038/32911 · Cited by 2,346
Oxidative Stress and Stress-Activated Signaling Pathways: A Unifying Hypothesis of Type 2 Diabetes
Evans, J. L., Goldfine, I. D., Maddux, B. A., & Grodsky, G. M. (2002) · Endocrine Reviews · doi:10.1210/er.2001-0039 · Cited by 2,232
Replication of Genome-Wide Association Signals in UK Samples Reveals Risk Loci for Type 2 Diabetes
Zeggini, E., Weedon, M. N., Lindgren, C. M., Frayling, T. M., Elliott, K. S., Lango, H., Timpson, N. J., Perry, J. R. B., Rayner, N. W., Freathy, R. M., et al. (2007) · Science · doi:10.1126/science.1142364 · Cited by 2,194
Research works printed but not linked: 1
- Shimabukuro M, Higa M, Zhou YT, Wang MY, Newgard CB, Unger RH 1998 Lipoapoptosis in β-cells of obese prediabetic fa/fa rats. Role of serine palmitoyltransferase overexpression. J Biol Chem 273:32487–32490 [DOI] [PubMed] [Google Scholar]
Cited by
Items 101–200 of 999
Ma, M., Liu, H., Yu, J., He, S., Li, P., Ma, C., Zhang, H., Xu, L., Ping, F., Li, W., et al. (2020) · Lipids in Health and Disease · doi:10.1186/s12944-020-01303-w · Cited by 160
Bachar, E., Ariav, Y., Ketzinel-Gilad, M., Cerasi, E., Kaiser, N., & Leibowitz, G. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004954 · Cited by 139
Role of the cAMP Pathway in Glucose and Lipid Metabolism
Ravnskjær, K., Madiraju, A. K., & Montminy, M. (2015) · Handbook of experimental pharmacology · doi:10.1007/164_2015_32 · Cited by 163
Lipotoxicity in the Pancreatic Beta Cell: Not Just Survival and Function, but Proliferation as Well?
Sharma, R. B., & Alonso, L. C. (2014) · Current Diabetes Reports · doi:10.1007/s11892-014-0492-2 · Cited by 136
Teixeira de Lemos, E., Oliveira, J., Páscoa Pinheiro, J., & Reis, F. (2012) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2012/741545 · Cited by 135
Teneligliptin: a DPP-4 inhibitor for the treatment of type 2 diabetes
Kishimoto, M. (2013) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s35682 · Cited by 158
Minireview: Estrogenic Protection of β-Cell Failure in Metabolic Diseases
Liu, S., & Mauvais-Jarvis, F. (2010) · Endocrinology · doi:10.1210/en.2009-1107 · Cited by 134
Alnahdi, A., John, A., & Raza, H. (2019) · Nutrients · doi:10.3390/nu11091979 · Cited by 134
Hyperglycemic Stress and Carbon Stress in Diabetic Glucotoxicity
Luo, X., Wu, J., Jing, S., & Yan, L. (2016) · Aging and Disease · doi:10.14336/ad.2015.0702 · Cited by 164
Roles of G protein-coupled estrogen receptor GPER in metabolic regulation
Sharma, G., Mauvais-Jarvis, F., & Prossnitz, E. R. (2018) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2017.02.012 · Cited by 131
“The ensuing lipotoxicity and glucotoxicity in the islets of the pancreas reduces insulin production from pancreatic b-cells, eventually leading to diabetes [12,13].”
Lenzen, S. (2017) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2017.05.013 · Cited by 137
Pancreatic β-cell identity in diabetes
Remedi, M. S., & Emfinger, C. (2016) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.12727 · Cited by 128
Amyot, J., Semache, M., Ferdaoussi, M., Fontés, G., & Poitout, V. (2012) · PLoS ONE · doi:10.1371/journal.pone.0036200 · Cited by 127
Self-citationAl-Trad, B., Alkhateeb, H., Alsmadi, W., & Al-Zoubi, M. (2019) · Life Sciences · doi:10.1016/j.lfs.2018.11.034 · Cited by 125
Chan, J. Y., Luzuriaga, J., Maxwell, E. L., West, P. K., Bensellam, M., & Laybutt, D. R. (2015) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2015.06.025 · Cited by 142
“Interestingly, this also indicates that oxidative stress and inflammation are not necessarily direct consequences of hyperglycaemia (Bensellam et al, 2012, Donath and Shoelson, 2011, Poitout and Robertson, 2008).”
BackgroundPax6 Is Crucial for β-Cell Function, Insulin Biosynthesis, and Glucose-Induced Insulin Secretion
Gosmain, Y., Katz, L. S., Masson, M. H., Cheyssac, C., Poisson, C., & Philippé, J. (2012) · Molecular Endocrinology · doi:10.1210/me.2011-1256 · Cited by 148
Update on the molecular biology of dyslipidemias
Ramasamy, I. (2015) · Clinica Chimica Acta · doi:10.1016/j.cca.2015.10.033 · Cited by 155
Saturated with fat: new perspectives on lipotoxicity
Garbarino, J., & Sturley, S. L. (2009) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0b013e32832182ee · Cited by 125
Loss of Bmal1 leads to uncoupling and impaired glucose-stimulated insulin secretion in β-cells
Lee, J., Kim, M.-S., Li, R., Liu, V. Y., Fu, L., Moore, D. D., Ma, K., & Yechoor, V. K. (2011) · Islets · doi:10.4161/isl.3.6.18157 · Cited by 124
Lin, Y., & Sun, Z. (2014) · Diabetes · doi:10.2337/db14-0632 · Cited by 136
“Hyperglycemia and hyperlipidemia cause oxidative damage to proteins, lipids, and DNA in b-cells as the result of a combination of increased free radical production and an impaired ability of cells to detoxify the radicals and repair damaged molecules (33).”
Chan, J. Y., Luzuriaga, J., Bensellam, M., Biden, T. J., & Laybutt, D. R. (2013) · Diabetes · doi:10.2337/db12-0701 · Cited by 123
“Oxidative stress has been proposed as a mechanism for gluco-lipotoxicity of b-cells (20,23).”
BackgroundLipid receptors and islet function: therapeutic implications?
Kebede, M. A., Alquier, T., Latour, M. G., & Poitout, V. (2009) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2009.01114.x · Cited by 122
Self-citationSmall G Proteins in Islet β-Cell Function
Kowluru, A. (2009) · Endocrine Reviews · doi:10.1210/er.2009-0022 · Cited by 132
Glucose regulation of islet stress responses and β‐cell failure in type 2 diabetes
Jonas, J. C., Bensellam, M., Duprez, J., Elouil, H., Guiot, Y., & Pascal, S. M. A. (2009) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2009.01112.x · Cited by 118
Green, C. D., & Olson, L. K. (2011) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00544.2010 · Cited by 125
Diakogiannaki, E., Welters, H. J., & Morgan, N. G. (2008) · Journal of Endocrinology · doi:10.1677/joe-08-0041 · Cited by 116
Scheen, A. J., & Paquot, N. (2014) · Diabetes & Metabolism · doi:10.1016/s1262-3636(14)72689-8 · Cited by 125
“However, such a predisposition can be precipitated and worsened by toxic effects of hyperglycaemia (glucose toxicity or glucotoxicity) and elevated levels of free fatty acids (lipotoxicity) [2,3].”
BackgroundAichler, M., Borgmann, D. M., Krumsiek, J., Buck, A., MacDonald, P. E., Fox, J. E. M., Lyon, J. G., Light, P. E., Keipert, S., Jastroch, M., et al. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2017.04.012 · Cited by 121
Unveiling Gestational Diabetes: An Overview of Pathophysiology and Management
Mittal, R., Prasad, K., Lemos, J. R. N., Arevalo, G., & Hirani, K. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26052320 · Cited by 183
“12 of 42 Excess FFAs activate stress pathways such as protein kinase C (PKC) and JNK signaling, leading to β - cell in fl ammation and apoptosis [197–200]. cell dysfunction [196].”
Pancreatic α Cells are Resistant to Metabolic Stress-induced Apoptosis in Type 2 Diabetes
Marroqui, L., Masini, M., Merino, B., Grieco, F. A., Millard, I., Dubois, C., Quesada, I., Marchetti, P., Cnop, M., & Eizirik, D. L. (2015) · EBioMedicine · doi:10.1016/j.ebiom.2015.03.012 · Cited by 114
Marselli, L., Piron, A., Suleiman, M., Colli, M. L., Yi, X., Khamis, A., Carrat, G., Rutter, G. A., Bugliani, M., Giusti, L., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.108466 · Cited by 134
Bagge, A., Clausen, T. R., Larsen, S., Ladefoged, M., Rosenstierne, M. W., Larsen, L., Vang, O., Nielsen, J. H., & Dalgaard, L. T. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.08.082 · Cited by 123
“Prolonged exposure of beta-cells to high levels of glucose decreases GSIS [2,30].”
Diabetes fuels periodontal lesions via GLUT1-driven macrophage inflammaging
Wang, Q., Nie, L., Zhao, P., Zhou, X., Ding, Y., Chen, Q., & Wang, Q. (2021) · International Journal of Oral Science · doi:10.1038/s41368-021-00116-6 · Cited by 125
Yamabe, N., Noh, J. S., Park, C. H., Kang, K. S., Shibahara, N., Tanaka, T., & Yokozawa, T. (2010) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2010.08.044 · Cited by 110
G protein-coupled receptors as targets for anti-diabetic therapeutics
Oh, D. Y., & Olefsky, J. M. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2015.4 · Cited by 117
ZHANG, W., XU, Y.-C., GUO, F.-J., MENG, Y., & LI, M.-L. (2008) · Chinese Medical Journal · doi:10.1097/00029330-200811010-00003 · Cited by 109
Levitt, H. E., Cyphert, T. J., Pascoe, J. L., Hollern, D. A., Abraham, N., Lundell, R. J., Rosa, T., Romano, L. C., Zou, B., O’Donnell, C. P., et al. (2011) · Diabetologia · doi:10.1007/s00125-010-1919-1 · Cited by 109
“Although there is strong evidence in the literature suggesting that chronic exposure to high glucose results in beta cell death [43] we did not detect this effect, even though several of the grafts were exposed to high blood glucose for longer than 2 weeks.”
BackgroundStress-impaired transcription factor expression and insulin secretion in transplanted human islets
Dai, C., Kayton, N. S., Shostak, A., Poffenberger, G., Cyphert, H. A., Aramandla, R., Thompson, C., Papagiannis, I. G., Emfinger, C., Shiota, M., et al. (2016) · Journal of Clinical Investigation · doi:10.1172/jci83657 · Cited by 109
“Oxidative stress from increased levels of ROS is widely hypothesized as a cause of β cell dysfunction (2, 52).”
BackgroundBeta-Cell Mass in Obesity and Type 2 Diabetes, and Its Relation to Pancreas Fat: A Mini-Review
Inaishi, J., & Saisho, Y. (2020) · Nutrients · doi:10.3390/nu12123846 · Cited by 107
“In addition, hyperglycemia and high pancreas fat content augment the decline of the decline of beta-cell mass by gluco(lipo)toxicity [36].”
BackgroundMakni, M., Fetoui, H., Gargouri, N. K., Garoui, E. M., & Zeghal, N. (2010) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2010.09.001 · Cited by 127
Targeting lipid GPCRs to treat type 2 diabetes mellitus — progress and challenges
Ghislain, J. J., & Poitout, V. (2021) · Nature Reviews Endocrinology · doi:10.1038/s41574-020-00459-w · Cited by 116
Self-citationVéret, J., Coant, N., Berdyshev, E. V., Skobeleva, A., Therville, N., Bailbé, D., Gorshkova, I. A., Natarajan, V., Portha, B., & Stunff, H. L. (2011) · Biochemical Journal · doi:10.1042/bj20101386 · Cited by 121
Lim, S., Rashid, M. A., Jang, M., Kim, Y., Won, H., Lee, J., Woo, J.-T., Kim, Y. S., Murphy, M. P., Ali, L., et al. (2011) · Cellular Physiology and Biochemistry · doi:10.1159/000335802 · Cited by 107
Plasma Heme Oxygenase-1 Concentration Is Elevated in Individuals with Type 2 Diabetes Mellitus
Bao, W., Song, F., Li, X., Rong, S., Yang, W., Zhang, M., Yao, P., Hao, L., Yang, N., Hu, F. B., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012371 · Cited by 104
Alarcón, C., Boland, B. B., Uchizono, Y., Moore, P. C., Peterson, B. F., Rajan, S., Rhodes, O. S., Noske, A. B., Haataja, L., Arvan, P. R., et al. (2015) · Diabetes · doi:10.2337/db15-0792 · Cited by 102
Widenmaier, S. B., Kim, S.-J., Yang, G. K., De Los Reyes, T., Nian, C., Asadi, A., Seino, Y., Kieffer, T. J., Kwok, Y. N., & McIntosh, C. H. S. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009590 · Cited by 102
Speck, M., Cho, Y. M., Asadi, A., Rubino, F., & Kieffer, T. J. (2011) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00422.2010 · Cited by 108
The RISE Consortium (2014) · Diabetes Care · doi:10.2337/dc13-1879 · Cited by 100
Lakshmanan, A. P., Harima, M., Suzuki, K., Soetikno, V., Nagata, M., Nakamura, T., Takahashi, T., Sone, H., Kawachi, H., & Watanabe, K. (2012) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2012.09.017 · Cited by 103
Ye, R., Holland, W. L., Gordillo, R., Wang, M., Wang, Q. A., Shao, M., Morley, T. S., Gupta, R. K., Stahl, A., & Scherer, P. E. (2014) · eLife · doi:10.7554/elife.03851 · Cited by 100
Taniguchi, S., Kang, L., Kimura, T., & Niki, I. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.01119.x · Cited by 101
MRI-determined fat content of human liver, pancreas and kidney
Sijens, P. E. (2010) · World Journal of Gastroenterology · doi:10.3748/wjg.v16.i16.1993 · Cited by 98
Functional pancreatic beta-cell mass: Involvement in type 2 diabetes and therapeutic intervention
Karaca, M., Magnan, C., & Kargar, C. (2009) · Diabetes & Metabolism · doi:10.1016/j.diabet.2008.09.007 · Cited by 114
Kokil, G. R., Veedu, R. N., Ramm, G. A., Prins, J. B., & Parekh, H. S. (2015) · Chemical Reviews · doi:10.1021/cr5002832 · Cited by 109
Xiang, A. H., Kawakubo, M., Trigo, E., Kjos, S. L., & Buchanan, T. A. (2010) · Diabetes Care · doi:10.2337/dc09-1493 · Cited by 95
“Glucose and lipid toxicity have been suggested as causes of declining -cell function (7), although data are lacking from humans to support such an effect over the years that it takes to develop diabetes.”
BackgroundWidenmaier, S. B., Ao, Z., Kim, S.-J., Warnock, G., & McIntosh, C. H. S. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.060178 · Cited by 96
Imai, Y., Cousins, R. S., Liu, S., Phelps, B. M., & Promes, J. A. (2019) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.14037 · Cited by 100
Cui, W., Ma, J., Wang, X., Yang, W., Zhang, J., & Ji, Q. (2013) · PLoS ONE · doi:10.1371/journal.pone.0059921 · Cited by 104
β-Cell deterioration during diabetes: what’s in the gun?
Robertson, R. P. (2009) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2009.05.004 · Cited by 93
“The close clinical association of T2D with obesity led to research interest in fatty acids, a major product of lipolysis, as players in the deterioration of β-cell function in T2D [9,29].”
BackgroundResultInfluentialSelf-citationLiu, Z., Stanojevic, V., Avadhani, S., Yano, T., & Habener, J. F. (2011) · Diabetologia · doi:10.1007/s00125-011-2181-x · Cited by 93
El-Assaad, W., Joly, E., Barbeau, A., Sladek, R., Buteau, J., Maestre, I., Pepin, E., Zhao, S., Iglesias, J., Roche, E., et al. (2010) · Endocrinology · doi:10.1210/en.2009-1238 · Cited by 93
Kluth, O., Mirhashemi, F., Scherneck, S., Kaiser, D., Kluge, R., Neschen, S., Joost, H., & Schürmann, A. (2010) · Diabetologia · doi:10.1007/s00125-010-1973-8 · Cited by 102
“The two scenarios, lipotoxicity and glucotoxicity, are not mutually exclusive but may function in combination [25, 26].”
What role do fat cells play in pancreatic tissue?
Gerst, F., Wagner, R., Oquendo, M. B., Siegel-Axel, D., Fritsche, A., Heni, M., Staiger, H., Häring, H., & Ullrich, S. (2019) · Molecular Metabolism · doi:10.1016/j.molmet.2019.05.001 · Cited by 82
Role of pancreatic β ‐cell death and inflammation in diabetes
Quan, W., Jo, E., & Lee, M. ‐. (2013) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12153 · Cited by 103
Overnutrition, Ectopic Lipid and the Metabolic Syndrome
Grundy, S. M. (2016) · Journal of Investigative Medicine · doi:10.1136/jim-2016-000155 · Cited by 117
Savu, O., Ionescu-Tirgoviste, C., Atanasiu, V., Gaman, L. E., Papacocea, R. I., & Stoian, I. A.-M. (2012) · Journal of International Medical Research · doi:10.1177/147323001204000235 · Cited by 101
Cholesterol metabolism and pancreatic β-cell function
Fryirs, M. A., Barter, P. J., & Rye, K. (2009) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e32832ac180 · Cited by 92
Insulin Resistance in Type 1 Diabetes: Pathophysiological, Clinical, and Therapeutic Relevance
Apostolopoulou, M., Lambadiari, V., Roden, M., & Dimitriadis, G. D. (2025) · Endocrine Reviews · doi:10.1210/endrev/bnae032 · Cited by 90
Pancreatic steatosis in humans: cause or marker of lipotoxicity?
van Raalte, D. H., van der Zijl, N. J., & Diamant, M. (2010) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/mco.0b013e32833aa1ef · Cited by 90
Review of the Correlation of LAT1 With Diseases: Mechanism and Treatment
Zhang, J., Xu, Y., Li, D., Fu, L., Zhang, X., Bao, Y.-G., & Zheng, L. (2020) · Frontiers in Chemistry · doi:10.3389/fchem.2020.564809 · Cited by 96
Autophagy in adipose tissue and the beta cell: implications for obesity and diabetes
Stienstra, R., Haim, Y., Riahi, Y., Netea, M. G., Rudich, A., & Leibowitz, G. (2014) · Diabetologia · doi:10.1007/s00125-014-3255-3 · Cited by 99
“This, together with oxidative stress elicited by excessive mitochondrial generation of reactive oxygen species, leads to beta cell dysfunction [56, 57].”
BackgroundG-Protein-Coupled Estrogen Receptor (GPER) and Sex-Specific Metabolic Homeostasis
Sharma, G., & Prossnitz, E. R. (2017) · Advances in Experimental Medicine and Biology · doi:10.1007/978-3-319-70178-3_20 · Cited by 88
“The ensuing glucotoxicity, lipotoxicity, and inflammation result in dysfunction of these tissues, including defects in insulin production and secretion by the pancreas, inhibition of insulin-stimulated glucose uptake in skeletal muscle, and increases in glucose production by the liver (Consitt et al. 2009; Muoio and N…”
BackgroundRedox signaling in the pancreas in health and disease
Sastre, J., Pérez, S., Sabater-Orti, L., & Rius‐Pérez, S. (2024) · Physiological Reviews · doi:10.1152/physrev.00044.2023 · Cited by 111
β-cell apoptosis in type 2 diabetes: quantitative and functional consequences
Lupi, R., & Prato, S. D. (2008) · Diabetes & Metabolism · doi:10.1016/s1262-3636(08)73396-2 · Cited by 105
Sebbagh, N., Cruciani‐Guglielmacci, C., Ouali, F., Berthault, M., Rouch, C., Sari, D. C., & Magnan, C. (2009) · Diabetes & Metabolism · doi:10.1016/j.diabet.2008.10.005 · Cited by 103
Solomon, T. P. J., Malin, S. K., Karstoft, K., Kashyap, S. R., Haus, J. M., & Kirwan, J. P. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2232 · Cited by 87
“[24, 25]), and we (26) and others (27, 28) have demonstrated this experimentally in vivo.”
BackgroundWang, J., Wu, T., Fang, L., Liu, C., Liu, X., Li, H., Shi, J., Li, M., & Min, W. (2020) · Food & Function · doi:10.1039/d0fo01753a · Cited by 86
Characterisation of Age-Dependent Beta Cell Dynamics in the Male db/db Mice
Dalbøge, L. S., Almholt, D. L. C., Neerup, T. S. R., Vassiliadis, E., Vrang, N., Pedersen, L., Fosgerau, K., & Jelsing, J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0082813 · Cited by 100
“However, when the metabolic demands exceed the compensatory capacity of the increased beta cell mass and insulin secretion, hyperglycaemia and T2D will develop [5,12,13].”
BackgroundPoungvarin, N., Lee, J. K., Yechoor, V. K., Li, M. V., Assavapokee, T., Suksaranjit, P., Thepsongwajja, J. J., Saha, P. K., Oka, K., & Chan, L. (2012) · Diabetologia · doi:10.1007/s00125-012-2506-4 · Cited by 85
“There is now compelling evidence that glucotoxicity is responsible, at least in part, for the time-dependent deterioration of beta cell function [2, 4] and loss of beta cell mass [38, 39] in patients with type 2 diabetes.”
BackgroundLi, X., Zhen, M., Zhou, C., Deng, R., Yu, T., Wu, Y., Shu, C., Wang, C., & Bai, C. (2019) · ACS Nano · doi:10.1021/acsnano.9b02050 · Cited by 85
FoxO1 Plays an Important Role in Regulating β-Cell Compensation for Insulin Resistance in Male Mice
Zhang, T., Kim, D. H., Xiao, X., Lee, S., Gong, Z., Muzumdar, R. H., Calabuig-Navarro, V., Yamauchi, J., Harashima, H., Wang, R., et al. (2016) · Endocrinology · doi:10.1210/en.2015-1852 · Cited by 96
Nelson, R. W. (2015) · Elsevier eBooks · doi:10.1016/b978-1-4557-4456-5.00006-7 · Cited by 111
G-protein coupled receptors mediating long chain fatty acid signalling in the pancreatic beta-cell
Morgan, N. G., & Dhayal, S. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.07.020 · Cited by 101
Glucolipotoxicity and beta cells in type 2 diabetes mellitus: Target for durable therapy?
van Raalte, D. H., & Diamant, M. (2011) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(11)70012-2 · Cited by 99
GLP1-derived nonapeptide GLP1(28–36)amide protects pancreatic β-cells from glucolipotoxicity
Liu, Z., Stanojevic, V., Brindamour, L. J., & Habener, J. F. (2012) · Journal of Endocrinology · doi:10.1530/joe-11-0328 · Cited by 83
Mesarwi, O. A., Sharma, E. V., Jun, J. C., & Polotsky, V. Y. (2015) · Sleep and Biological Rhythms · doi:10.1111/sbr.12078 · Cited by 80
Yano, H., Kinoshita, M., Fujino, K., Nakashima, M., Yamamoto, Y., Miyazaki, H., Hamada, K., Ono, S., Iwaya, K., Saitoh, D., et al. (2012) · Infection and Immunity · doi:10.1128/iai.00787-12 · Cited by 92
“Although hyperglycemia-induced ROS production from -cell mitochondria is known to contribute to the development of insulin resistance and pancreatic -cell failure (25, 35), conflicting results have been reported about ROS production by neutrophils in diabetes.”
BackgroundFernández‐Millán, E., Ramos, S., Álvarez, C., Bravo, L., Goya, L., & Martín, M. Á. (2014) · Food and Chemical Toxicology · doi:10.1016/j.fct.2014.01.044 · Cited by 83
X-Box Binding Protein 1 Is Essential for Insulin Regulation of Pancreatic α-Cell Function
Akiyama, M., Liew, C. W., Lu, S., Hu, J., Martinez, R., Hambro, B., Kennedy, R. T., & Kulkarni, R. N. (2013) · Diabetes · doi:10.2337/db12-1747 · Cited by 80
Akiyama, M., Hatanaka, M., Ohta, Y., Ueda, K., Yanai, A., Uehara, Y., Tanabe, K., TSURU, M., Miyazaki, M., Saeki, S., et al. (2009) · Diabetologia · doi:10.1007/s00125-009-1270-6 · Cited by 87
“In addition to genetic factors, processes involving glucotoxicity and/or lipotoxicity are likely to be contributory [4].”
BackgroundKaneto, H., Obata, A., Kimura, T., Shimoda, M., Okauchi, S., Shimo, N., Matsuoka, T., & Kaku, K. (2016) · Journal of Diabetes · doi:10.1111/1753-0407.12494 · Cited by 92
Stancill, J. S., Cartailler, J., Clayton, H. W., O’Connor, J. T., Dickerson, M. T., Dadi, P. K., Osipovich, A. B., Jacobson, D. A., & Magnuson, M. A. (2017) · Diabetes · doi:10.2337/db16-1355 · Cited by 86
Gene-Diet Interactions in Type 2 Diabetes: The Chicken and Egg Debate
Ortega, Á., Berná, G., Rojas, A., Martín, F., & Soria, B. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18061188 · Cited by 96
“The possible mechanism of SFAs to induce inflammation and IR in adipocytes, which would imply involvement of oxidative stress through ROS in a toll-like receptor-4 and 2 (Tlr4, Tlr2), mediated inflammatory signalling.”
BackgroundInfluentialLipid Accumulation in Hearts Transplanted From Nondiabetic Donors to Diabetic Recipients
Marfella, R., Amarelli, C., Cacciatore, F., Balestrieri, M. L., Mansueto, G., D’Onofrio, N., Esposito, S., Mattucci, I., Salerno, G., FEO, M. D., et al. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.01.018 · Cited by 84
Roger, B., Papin, J., Vacher, P., Raoux, M., Mulot, A., Dubois, M., Kerr-Conte, J. A., Voy, B. H., Pattou, F. N., Charpentier, G., et al. (2010) · Diabetologia · doi:10.1007/s00125-010-1955-x · Cited by 89
“Chronically elevated glucose alters glucose detection, its metabolism and subsequent calcium handling [3] as well as 500 Preculture:”
Backgroundβ-cell failure in type 2 diabetes mellitus
Lencioni, C., Lupi, R., & Prato, S. D. (2008) · Current Diabetes Reports · doi:10.1007/s11892-008-0031-0 · Cited by 91
la Fleur, S. E., Luijendijk, M. C. M., van Rozen, A. J., Kalsbeek, A., & Adan, R. A. H. (2010) · International Journal of Obesity · doi:10.1038/ijo.2010.164 · Cited by 94
Rakshit, K., Hsu, T. W., & Matveyenko, A. V. (2016) · Diabetologia · doi:10.1007/s00125-015-3859-2 · Cited by 78
“production of reactive oxygen species and propensity for oxidative stress [29], an impaired ability to respond to oxidative stress in beta cell Bmal1 null mice likely contributed to overt”
BackgroundProtective effects of tea, red wine and cocoa in diabetes. Evidences from human studies
Martín, M. Á., Goya, L., & Ramos, S. (2017) · Food and Chemical Toxicology · doi:10.1016/j.fct.2017.09.015 · Cited by 94
Huang, L., Lin, J.-S., Aris, I. M., Yang, G., Chen, W., & Li, L. (2019) · Nutrients · doi:10.3390/nu11050998 · Cited by 86
Metadata
- Authors
- Poitout, V., & Robertson, R. P.
- Affiliations
- Pacific Northwest Research Institute (US)
- University of Washington (US)
- Corresponding author
- Poitout, Vincent
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 2008-05
- Volume
- 29
- Issue
- 3
- Pages
- 351-366
- ISSN
- 0163-769X (ISSN-L)
- 1945-7189
- PMC
- PMC2528858
- OpenAlex
- W2082515526
- Cited by
- 1,092
- References
- 198
- Citations by year
- 2026: 47 · 2025: 55 · 2024: 37 · 2023: 42 · 2022: 38 · 2021: 57 · 2020: 61 · 2019: 50 · 2018: 44 · 2017: 61 · 2016: 79 · 2015: 64 · 2014: 59 · 2013: 81 · 2012: 84
- FWCI
- 81.71
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Endocrine Reviews (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Canadian Institutes of Health Research (77686)
- National Institute of Diabetes and Digestive and Kidney Diseases (R-01-DK-38325, R01 DK 58096, R01DK038325, R01DK058096)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Endoplasmic Reticulum Stress and Disease
- Keywords
- glucolipotoxicity, glucotoxicity, lipotoxicity, type 2 diabetes, beta-cell dysfunction, hyperglycemia, hyperlipidemia, oxidative stress, insulin secretion, insulin gene expression, beta-cell death, insulin resistance, beta-cell compensation, beta-cell failure
- MeSH terms
- Animals, Diabetes Mellitus, Type 2, Energy Metabolism, Glucose, Humans, Lipid Metabolism, Insulin-Secreting Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.